Acylation-stimulating protein increases and correlates with increased progesterone levels during the luteal phase of the menstrual cycle

European Journal of Endocrinology

Volumn 160, Issue 2, 2009, Pages 301-307

  Saleh, Jumana ^a   Al Khanbashi, Manal ^a   Al Maarof, Majida ^a   Al Lawati, Mohsin ^a   Rizvi, Syed G ^a   Cianflone, Katherine ^b  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION STIMULATING PROTEIN; ESTRADIOL; ESTROGEN; INSULIN; PROGESTERONE; APOPROTEIN; COMPLEMENT C3A, DES ARG (77); COMPLEMENT C3A, DES-ARG-(77); COMPLEMENT COMPONENT C3A; FOLLITROPIN; LIPID; LUTEINIZING HORMONE;

ADULT; ARTICLE; BODY MASS; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LIPID STORAGE; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; OVULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; ACYLATION; ADIPOSE TISSUE; BLOOD; METABOLISM;

ACYLATION; ADIPOSE TISSUE; APOPROTEINS; COMPLEMENT C3A; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INSULIN; LIPIDS; LUTEAL PHASE; LUTEINIZING HORMONE; PROGESTERONE; YOUNG ADULT;

EID: 61449193314     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0784     Document Type: Article

References (46)

1. Sniderman AD, Maslowska M & Cianflone K. Of mice and men (and women) and the acylation-stimulating protein pathway. Current Opinion in Lipidology 2000 11 291-296.
2. Cianflone K, Roncari DAK, Maslowska M, Baldo A, Forden J & Sniderman AD. The adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 1994 33 9489-9495.
3. Cianflone K & Maslowska M. Differentiation induced production of ASP in human adipocytes. European Journal of Clinical Investigation 1995 25 817-825.
4. Murray I, Havel PJ, Sniderman AD & Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 2000 141 1041-1049.
5. Murray I, Sniderman AD, Havel PJ & Cianflone K. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. Journal of Biological Chemistry 1999 274 36219-36225.
6. Murray IA, Sniderman AD & Cianflone K. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein (ASP) in C57Bl/6 mice. American Journal of Physiology. Endocrinology and Metabolism 1999 277 E474-E480.
7. Saleh J, Blevins JE, Havel PJ, Barrett JA, Gietzen DW & Cianflone K. Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. International Journal of Obesity and Related Metabolic Disorders 2001 25 705-713.
8. Saleh J, Summers LKM, Cianflone K, Fielding BA, Sniderman AD & Frayn KN. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. Journal of Lipid Research 1998 39 884-891.
9. Cianflone K, Zakarian R, Couillard C, Delplanque B, Despres JP & Sniderman A. Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. Journal of Lipid Research 2004 45 124-131.
10. Cianflone K, Sniderman AD, Kalant D, Marliss EB & Gougeon R. Response of plasma ASP to a prolonged fast. International Journal of Obesity 1995 19 604-609.
11. Sniderman AD, Cianflone K & Eckel RH. Levels of acylation stimulating protein in obese women before and after moderate weight loss. International Journal of Obesity 1991 15 333-336.
12. Maslowska M, Vu H, Phelis S, Sniderman AD, Rhode BM, Blank D & Cianflone K. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. European Journal of Clinical Investigation 1999 29 679-686.
13. Cianflone K, Zhang XJ, Genest J Jr & Sniderman AD. Plasma acylation stimulating protein in coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 1239-1244.
14. Cianflone KM, Maslowska MH & Sniderman AD. Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein. Journal of Clinical Investigation 1990 85 722-730.
15. de Ridder CM, Bruning PF, Zonderland ML, Thijssen JH, Bonfrer JM, Blankenstein MA, Huisveld IA & Erich WB. Body fat mass, body fat distribution, and plasma hormones in early puberty in females. Journal of Clinical Endocrinology and Metabolism 1990 70 888-893.
16. Chumlea WC, Roche AF, Siervogel RM, Knittle JL & Webb P. Adipocytes and adiposity in adults. American Journal of Clinical Nutrition 1981 34 1798-1803.
17. Chumlea WC, Knittle JL, Roche AF, Siervogel RM & Webb P. Size and number of adipocytes and measures of body fat in boys and girls 10 to 18 years of age. American Journal of Clinical Nutrition 1981 34 1791-1797.
18. Ferin M, Jewelewicz R & Warren M. The menstrual cycle: physiology, reproductive disorders, and infertility. New England Journal of Medicine 1994 330 1097.
19. Landgren BM, Unden AL & Diczfalusy E. Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinologica 1980 94 89-98.
20. Ley CJ, Lees B & Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. American Journal of Clinical Nutrition 1992 55 950-954.
21. Tchernof A, Poehlman ET & Després JP. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes & Metabolism 2000 26 12-20.
22. Poehlman E, Toth MJ & Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Annals of Internal Medicine 1995 123 673-675.
23. Norton M, Buchanan TA & Kitzmiller J. Endocrine pancreas and maternal metabolism. In Maternal-Fetal Endocrinology, pp 48-77. Eds D Tulchinsky & A Brian Little, Philadelphia, PA: W.B Saunders Company, 1994.
24. Blackburn ST & Loper DL. Carbohydrate, fat, and protein metabolism. In Maternal, Fetal and Neonatal Physiology, A Clinical Perspective, pp 583-613. Ed. T Eoyang, Philadelphia, PA: W.B Saunders Company, 1992.
25. Berneis K, Rizzo M, Lazzarini V, Fruzzetti F & Carmina E. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2007 92 186-189.
26. Saleh J, Cianflone K, Chaudhary T, Al-Riyami H, Al-Abri A & Bayoumi R. Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation. Obesity 2007 15 646-652.
27. Lobo MJ, Remesar X & Alemany M. Effect of chronic intravenous injection of steroid hormones on body weight and composition of female rats. Biochemistry and Molecular Biology International 1993 29 349-358.
28. Mendes AM, Madon RJ & Flint DJ. Effects of cortisol and progesterone on insulin binding and lipogenesis in adipocytes from normal and diabetic rats. Journal of Endocrinology 1985 106 225-231.
29. Kalkhoff RK. Metabolic effects of progesterone. American Journal of Obstetrics and Gynecology 1982 142 735-738.
30. Homma H, Kurachi H, Nishio Y, Takeda T, Yamamoto T, Adachi K, Morishige K-I, Ohmichi M, Matsuzawa Y & Murata Y. Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. Journal of Biological Chemistry 2000 275 11404-11411.
31. Cooke PS & Naaz A. Role of estrogens in adipocyte development and function. Experimental Biology and Medicine 2004 229 1127-1135.
32. Cucinelli F, Paparella P, Soranna L, Barini A, Cinque B, Mancuso S & Lanzone A. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. European Journal of Endocrinology 1999 140 215-223.
33. Hardie L, Trayhurn P, Abramovich D & Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clinical Endocrinology 1997 47 101-106.
34. Cella F, Giordano G & Cordera R. Serum leptin concentrations during the menstrual cycle in normal-weight women: effects of an oral triphasic estrogen-progestin medication. European Journal of Endocrinology 2000 142 174-178.
35. Ludwig M, Klein HH, Diedrich K & Ortmann O. Serum leptin concentrations throughout the menstrual cycle. Archives of Gynecology and Obstetrics 2000 263 99-101.
36. Kleiblová P, Springer D & Haluzík M. The influence of hormonal changes during menstrual cycle on serum adiponectin concentrations in healthy women. Physiological Research 2006 55 661-666.
37. Juul A, Scheike T, Pedersen AT, Main KM, Andersson AM, Pedersen LM & Skakkebaek NE. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. Human Reproduction 1997 12 2123-2128.
38. Riad-Gabriel M, Jinagouda SD, Sharma A, Boyadjian R & Saad M. Changes in plasma leptin during the menstrual cycle. European Journal of Endocrinology 1998 139 528-531.
39. Saleh J, Christou N & Cianflone K. Regional specificity of ASP binding in human adipose tissue. American Journal of Physiology 1999 276 E815-E821.
40. Hasty LA, Lambris JD, Lessey BA, Pruksananonda K & Lyttle CR. Hormonal regulation of complement components and receptors throughout the menstrual cycle. American Journal of Obstetrics and Gynecology 1994 170 168-175.
41. Hasty LA, Brockman WW, Lambris JD & Lyttle CR. Hormonal regulation of complement factor B in human endometrium. American Journal of Reproductive Immunology 1993 30 363-367.
42. Lacasa D, Le Liepvre X, Ferre P & Dugail I. Progesterone stimulates adipocyte determination and differentiation 1/sterol regulatory element-binding protein 1c gene expression. Potential mechanism for the lipogenic effect of progesterone in adipose tissue. Journal of Biological Chemistry 2001 276 11512-11516.
43. Wu Y, Zhang J, Wen Y, Wang H, Zhang M & Cianflone K. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertility and Sterility, 2008 DOI: 10.1016/j.fertnstert.2007.11.031.
44. Barnett JB, Woods MN, Lamon-Fava S, Schaefer EJ, McNamara JR, Spiegelman D, Hertzmark E, Goldin B, Longcope C & Gorbach SL. Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 2004 89 776-782.
45. Woods M, Schaefer EJ, Morrill A, Goldin BR, Longcope C, Dwyer JD & Gorbach SL. Effect of menstrual cycle phase on plasma lipids. Journal of Clinical Endocrinology and Metabolism 1987 65 321-323.
46. Muesing RA, Forman MR, Graubard BI, Beecher GR, Lanza E, McAdam PA, Campbell WS & Olson BR. Cyclic changes in lipoprotein and apolipoprotein levels during the menstrual cycle in healthy premenopausal women on a controlled diet. Journal of Clinical Endocrinology and Metabolism 1996 81 3599-3603.